FMR LLC 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 11:30 am Purchase | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | FMR LLC | 5,970,638 15.000% | 1,488,029 (+33.20%) | Filing |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | Dianthus Therapeutics, Inc. DNTH | FMR LLC | 4,482,609 14.000% | 2,264,397 (+102.08%) | Filing |
| 2023-11-13 09:02 am Purchase | 2023-11-10 | 13G | Dianthus Therapeutics, Inc. DNTH | FMR LLC | 2,218,212 14.970% | 2,218,212 (New Position) | Filing |